+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genfit - logo

GENFIT is a biopharmaceutical company that focuses on developing diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Its lead pipeline product elafibranor (GFT505) has recently completed a positive Phase 2b study in NASH (Non-Alcoholic Steato-Hepatitis). Genfit SA was founded in 1999 and is headquartered in Loos, France.

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Licensing Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2024

  • Report
  • March 2024
  • 1100 Pages
  • Global
From
Global Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Forecast 2024-2030 - Product Thumbnail Image

Global Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Forecast 2024-2030

  • Report
  • May 2024
  • 196 Pages
  • Global
From
Global Liposomal Products Market 2023-2027 - Product Thumbnail Image

Global Liposomal Products Market 2023-2027

  • Report
  • February 2023
  • 163 Pages
  • Global
From
Non-alcoholic Steatohepatitis Biomarker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Non-alcoholic Steatohepatitis Biomarker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 103 Pages
  • Global
From
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • September 2023
  • 182 Pages
  • Global
From
PPAR-Beta / Delta Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

PPAR-Beta / Delta Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • July 2020
  • 154 Pages
  • Global
From
Genfit SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Genfit SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Loading Indicator